Concizumab, Elranatamab & Talquetamab Among New EU Filings At EMA

The EMA has begun reviewing EU marketing applications for new drugs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography